//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
Exciting stuff! “Ensitrelvir administered to household contacts of a patient with Covid-19 within 72 hours after symptom onset in the index patient was effective in preventing Covid-19 in the contacts.” Covid incidence in the ensitrelvir group was 2.9% compared to 9.0% for placebo (RR 0.33).
1mo
C.H. Romatowski
Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts | New England Journal of Medicine www.nejm.org/doi/10.1056/...
1mo
Ensitrelvir, an oral inhibitor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 3C-like protease, is approved in Japan for the treatment of mild-to-moderate coronavirus disease 2019 ...
www.nejm.org
Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts | NEJM
Dick Zoutman